Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Operating Activities
Net income	$ 3,463	$ 3,427
Adjustments to reconcile net income to net cash flows provided by operating activities:
Change in deferred policy acquisition costs	2,950	3,870
Depreciation and amortization	2,220	1,635
Deferred income tax expense	(2,143)	1,967
Net realized (gains) losses	3	(95)
Stock-based compensation expense	179	268
Amortization of premiums and discounts on investments	312	109
Non-controlling interest	18	(174)
Changes in operating assets and liabilities, net of the effects of acquisitions
Accrued investment income	2	(100)
Other receivables	(18,707)	1,825
Reinsurance recoverables	8,319	7,708
Other assets	234	1,539
Unpaid claims	(86)	(2,159)
Unearned premiums	(6,870)	(9,842)
Policyholder account balances	(475)
Accrued expenses, accounts payable and other liabilities	6,832	(4,528)
Deferred revenue	(3,164)	(2,919)
Net cash flows (used in) provided by operating activities	(6,913)	2,531
Investing activities
Proceeds from maturities, calls and prepayments of available-for-sale investments	6,490	1,201
Proceeds from sales of available-for-sale investments	2,050	7,238
Proceeds from maturities of short term investments	150	100
Purchases of available-for-sale investments	(7,968)	(8,391)
Purchases of property and equipment	(1,800)	(2,463)
Net (paid) for acquisitions of subsidiaries, net of cash received	0	(40,752)
Proceeds from notes receivable	(199)	42
Change in restricted cash	(4,779)	3,929
Net cash flows used in investing activities	(6,056)	(39,096)
Financing activities
Payments on notes payable	(23,000)	(26,000)
Proceeds from notes payable	24,700	50,750
Capitalized closing costs for notes payable	0	(2,486)
Payments for intial public offering costs	0	(663)
Payments on redeemable preferred stock	0	(10,465)
Net proceeds from exercise of stock options	0	400
(Purchase) issuance of treasury stock	(1,394)	0
Net cash flows provided by financing activities	306	11,536
Net (decrease) increase in cash and cash equivalents	(12,663)	(25,029)
Cash and cash equivalents, beginning of period	31,339	43,389
Cash and cash equivalents, end of period	$ 18,676	$ 18,360